About: Chapter 31 Blood, blood components, plasma, and plasma products

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chapter 31 Blood, blood components, plasma, and plasma products Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Chapter 31 Blood, blood components, plasma, and plasma products
Creator	Plasma Products, Plasma,
source	Elsevier; PMC
abstract	Abstract This review of 2018 publications identifies side effects of blood, blood components, and plasma products. In addition, albumin, blood transfusion (erythrocytes, granulocytes, and platelets), blood substitutes (hemoglobin-based oxygen carriers), plasma products (alpha1-antitrypsin, C1 esterase inhibitor concentrate, cryoprecipitate, and fresh frozen plasma), plasma substitutes (etherified starches, and gelatin), globulins (intravenous immunoglobulin, subcutaneous immunoglobulin, and anti-D immunoglobulin), coagulation proteins (factor I, factor II, factor VIIa, factor VIII, factor IX, prothrombin complex concentrate, antithrombin III, and von Willebrand factor/factor VIII concentrates), erythropoietin and derivatives, thrombopoietin and receptor agonists, transmission of infectious agents through blood donation, and stem cells are reviewed. This chapter informs the reader about newly recognized and published data in the blood product domain.
has issue date	2019-12-31(xsd:dateTime)
bibo:doi	10.1016/bs.seda.2019.07.007
has license	els-covid
sha1sum (hex)	9df962127efd8e92186987d919811a53fa485084
schema:url	https://doi.org/10.1016/bs.seda.2019.07.007
resource representing a document's title	Chapter 31 Blood, blood components, plasma, and plasma products
has PubMed Central identifier	PMC7148809
schema:publication	Side Effects of Drugs Annual
resource representing a document's body	covid:9df962127efd8e92186987d919811a53fa485084#body_text
is schema:about of	named entity 'plasma' named entity 'BLOOD' named entity 'PLASMA' named entity 'BLOOD COMPONENTS' named entity 'PLASMA PRODUCTS' named entity 'thromboembolic' named entity 'double-blinded' named entity 'eltrombopag' named entity 'Ringer's solution' named entity 'Immune thrombocytopenia' named entity 'myocardial infarction' named entity 'heterogeneity' named entity 'computed tomography' named entity 'X-linked agammaglobulinemia' named entity 'half-life' named entity 'randomized controlled trials' named entity 'focal neurological signs' named entity 'Antithrombin III' named entity 'myelodysplastic syndromes' named entity 'chills' named entity 'pathogen' named entity 'IVIG' named entity 'VWF' named entity 'retrospective study' named entity 'randomized, placebo-controlled trial' named entity 'neutrophil gelatinase-associated lipocalin' named entity 'EPO' named entity 'Hemoglobin-based oxygen carrier' named entity 'case report' named entity 'non-significant' named entity 'succinylated' named entity 'neurologic' named entity 'PRES' named entity 'fatigue' named entity 'genetic condition' named entity 'tolerability' named entity 'C1 esterase inhibitor' named entity 'ITP' named entity 'parallel-group' named entity 'multicenter trial' named entity 'major surgery' named entity 'human plasma' named entity 'pulmonary complications' named entity 'allergic' named entity 'anaphylaxis' named entity 'SCIG' named entity 'viral pathogen' named entity 'emergency department' named entity 'emphysema' named entity 'CIDP' named entity 'standard treatment' named entity 'retrospective review' named entity 'HSCT' named entity 'congenital heart disease' named entity 'cardiovascular risk' named entity 'fractionation' named entity 'fibrinogen' named entity 'icatibant' named entity 'bone pain' named entity 'therapeutic treatment' named entity 'hypogammaglobulinemia' named entity 'headache' named entity 'aGVHD' named entity 'ITP' named entity 'RBC' named entity 'ITP' named entity 'parvovirus B19' named entity 'case series' named entity 'C1 esterase inhibitor' named entity 'off-label' named entity 'Thromboembolism' named entity 'alpha-1 antitrypsin' named entity 'randomized controlled trials' named entity 'thrombocytopenia' named entity 'cystatin' named entity 'RBC' named entity 'vomiting' named entity 'PCC' named entity 'CKD' named entity 'polyethylene glycol' named entity 'normal saline' named entity 'nausea'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software